ACE and obesity due to melanocortin 4 receptor deficiency: Our findings (Tables 1, 2, 5, 6) suggest ACE significantly improves BMI, body weight, perimenopausal symptoms, and estradiol levels, potentially establishing it as a promising therapeutic strategy for perimenopausal obesity based on current evidence.